Fructose Injection 5g/250mL

Fructose Injection 5g/250mL: What the Published Guidance Says

Crystalloid infusion solutions, energy substrates and parenteral nutrition components — the fluid-resuscitation and supportive-care layer underneath almost every inpatient protocol.

Fructose Injection 5g/250mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the IV Fluids range overview.

• Electrolyte composition is what separates saline from balanced solutions The Model List publishes the electrolyte content of each crystalloid it carries: sodium chloride 0.9% at Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L, the 5% + 0.9% glucose/sodium chloride combination at 150 mmol/L, and the 5% + 0.45% combination at 75 mmol/L. Comparing those figures against plasma composition is how a formulary committee decides which fluid to standardise on — and why lactated Ringer's, with a more physiological profile, is frequently the resuscitation default. WHO eEML — Glucose + sodium chloride
• The Model List specifies the crystalloid formulations The 24th WHO Model List (2025) carries sodium chloride 0.9% isotonic (equivalent to Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L) and glucose + sodium chloride combinations of 4% + 0.18%, 5% + 0.9% and 5% + 0.45%, classified under solutions correcting water, electrolyte and acid-base disturbances. Glucose + sodium chloride was first added in 1979. WHO eEML — Glucose + sodium chloride
• Presentation is part of the specification WHO's criterion for an essential medicine includes that it be available in appropriate dosage forms for the intended uses and patients. For infusion solutions that criterion is expressed as fill volume and container format — the difference between a 500 mL bottle and a 1 L bag is a formulary decision before it becomes a price decision. WHO — Essential medicines (fact sheet)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Fructose Injection 5g/250mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Fructose Injection 5g/250mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities
• Testing for packaging integrity and seal testing
• Testing for description and identification

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

• Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
• Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

Documents for Fructose Injection 5g/250mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
• Batch manufacturing and packaging records released for inspection on request during supplier audits.
• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.

The context for Fructose Injection 5g/250mL is its place among infusion solutions and parenteral nutrition named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Other IV Fluids Products in This Range

• Human Albumin 20% 50ml — 100g
• 20% Fat Emulsion Injection 100ml — 100mL
• Lactated Ringer’s Injection 500mL — 500mL
• 10% Dextrose Injection 500ml — 10g
• 5% Dextrose Injection 500ml — 5000IU

Browse the full IV Fluids range; all Injectables; the complete product catalogue.